Enlaza Therapeutics Overview
- Year Founded
-
2020

- Status
-
Private
- Employees
-
48

- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$100M
- Investors
-
14
Enlaza Therapeutics General Information
Description
Developer of covalent protein therapeutics intended to offer safer treatments. The company offers a novel synthetic biology platform that uses covalent bonds to lock onto a target protein to provide sustained occupancy and prolonged biologic effect with minimal systemic exposure, enabling healthcare professionals to treat various diseases.
Contact Information
Website
www.enlazatx.comCorporate Office
- 11099 North Torrey Pines Road
- Suite 280, La Jolla
- San Diego, CA 92037
- United States
Corporate Office
- 11099 North Torrey Pines Road
- Suite 280, La Jolla
- San Diego, CA 92037
- United States
Enlaza Therapeutics Timeline
Enlaza Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Early Stage VC (Series A) | 30-Apr-2024 | $100M | Completed | Startup | ||
1. Seed Round | 15-Dec-2022 | Completed | Startup |
Enlaza Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Enlaza Therapeutics Comparisons
Industry
Financing
Details
Enlaza Therapeutics Competitors (3)
One of Enlaza Therapeutics’s 3 competitors is Dunad Therapeutics, a Venture Capital-Backed company based in Cambridge, United Kingdom.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Dunad Therapeutics | Venture Capital-Backed | Cambridge, United Kingdom | ||||
Avilar Therapeutics | Venture Capital-Backed | Waltham, MA | ||||
Matchpoint Therapeutics | Venture Capital-Backed | Cambridge, MA |
Enlaza Therapeutics Patents
Enlaza Therapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2023275779-A1 | Crosslinking multispecific antibodies | Pending | 27-May-2022 | ||
CA-3241897-A1 | Crosslinking antibodies | Pending | 22-Dec-2021 | ||
AU-2022419596-A1 | Crosslinking antibodies | Pending | 22-Dec-2021 | ||
EP-4452333-A1 | Crosslinking antibodies | Pending | 22-Dec-2021 | A61K47/6869 |
Enlaza Therapeutics Signals
Enlaza Therapeutics Investors (14)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Alexandria Venture Investments | Venture Capital | Minority | ||
Amgen Ventures | Corporate Venture Capital | Minority | ||
Avalon Ventures | Venture Capital | Minority | ||
Bregua Corporation | Venture Capital | Minority | ||
Frazier Healthcare Partners | PE/Buyout | Minority |
Enlaza Therapeutics FAQs
-
When was Enlaza Therapeutics founded?
Enlaza Therapeutics was founded in 2020.
-
Where is Enlaza Therapeutics headquartered?
Enlaza Therapeutics is headquartered in San Diego, CA.
-
What is the size of Enlaza Therapeutics?
Enlaza Therapeutics has 48 total employees.
-
What industry is Enlaza Therapeutics in?
Enlaza Therapeutics’s primary industry is Drug Discovery.
-
Is Enlaza Therapeutics a private or public company?
Enlaza Therapeutics is a Private company.
-
What is the current valuation of Enlaza Therapeutics?
The current valuation of Enlaza Therapeutics is
. -
What is Enlaza Therapeutics’s current revenue?
The current revenue for Enlaza Therapeutics is
. -
How much funding has Enlaza Therapeutics raised over time?
Enlaza Therapeutics has raised $161M.
-
Who are Enlaza Therapeutics’s investors?
Alexandria Venture Investments, Amgen Ventures, Avalon Ventures, Bregua Corporation, and Frazier Healthcare Partners are 5 of 14 investors who have invested in Enlaza Therapeutics.
-
Who are Enlaza Therapeutics’s competitors?
Dunad Therapeutics, Avilar Therapeutics, and Matchpoint Therapeutics are competitors of Enlaza Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »